DIEP皮瓣乳房重建中延长与住院期间药物预防静脉血栓栓塞的比较:系统综述与Meta分析
该系统综述与Meta分析纳入4项研究共1114例DIEP皮瓣乳房重建患者,比较短期与长期药物预防对静脉血栓栓塞(VTE)和血肿的影响。VTE总体发生率为1.83%,短期组2.19% vs 长期组1.33%,风险比(RR)为1.42(P=.62);血肿平均发生率8.65%,短期组8.32% vs 长期组9.02%,RR为0.78(P=.25),均无统计学显著差异。
要点
- 纳入4项研究共1114例,短期与长期药物预防组患者特征(含Caprini评分)无显著差异。
- VTE总体发生率1.83%,短期组2.19% vs 长期组1.33%,RR 1.42(P=.62),无统计学显著差异。
- 血肿平均发生率8.65%,短期组8.32% vs 长期组9.02%,RR 0.78(P=.25),无统计学显著差异。
核心结论
- 延长药物预防至住院期间之后并未显著降低VTE发生率,强调基于个体化风险的抗凝策略的重要性。
- 未来研究有必要进一步细化该人群药物预防时长的指南,以平衡VTE与抗凝相关并发症风险。
研究设计与样本
- 系统综述与Meta分析,纳入4项研究共1114例接受DIEP皮瓣乳房重建的患者。
- 比较短期药物预防(STC)与长期药物预防(LTC)预防VTE和血肿的疗效与安全性。
- 短期与长期药物预防组患者特征(包括Caprini评分)无显著差异。
主要发现
- VTE总体发生率为1.83%,短期药物预防组为2.19%,长期药物预防组为1.33%。
- 短期药物预防相比长期药物预防的VTE风险比(RR)为1.42,未达统计学显著(P=.62)。
- 血肿平均发生率为8.65%,短期药物预防组为8.32%,长期药物预防组为9.02%。
- 短期药物预防相比长期药物预防的血肿RR为0.78,未达统计学显著(P=.25)。
临床怎么用
- 研究结果提示延长药物预防至住院之后并未显著降低VTE发生率,强调基于个体化风险的抗凝策略的重要性。
- 未来研究有必要进一步细化该人群药物预防时长的指南。
局限性
- 未来研究有必要进一步细化该人群药物预防时长的指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Venous thromboembolism (VTE) is a significant complication following deep inferior epigastric artery perforator (DIEP) flap breast reconstruction. The optimal duration of chemoprophylaxis remains debated, with differing recommendations on short-term chemoprophylaxis (STC) vs long-term chemoprophylaxis (LTC) for VTE prevention. This systematic review and meta-analysis compared the efficacy and safety of STC vs LTC in preventing VTE and hematoma in patients undergoing DIEP flap reconstruction. Four studies with a total of 1114 patients were included, with no significant differences in patient characteristics, including Caprini scores, between the STC and LTC groups. The pooled incidence of VTE was 1.83%, with 2.19% in the STC group and 1.33% in the LTC group, yielding a risk ratio (RR) of 1.42 for STC compared to LTC, although this was not statistically significant (P = .62). The mean incidence of hematoma was 8.65%, with 8.32% in the STC group and 9.02% in the LTC group, resulting in an RR of 0.78 for STC compared to LTC, which was also not statistically significant (P = .25). These findings suggest that extending chemoprophylaxis beyond hospitalization does not significantly reduce VTE incidence and underscores the importance of individualized risk-based anticoagulation strategies. Future studies are necessary to further refine guidelines for chemoprophylaxis duration in this population, balancing the risks of VTE and anticoagulation-related complications to optimize patient outcomes.
引用
- Hinson C, Sink M, Buntic RF, et al. Extended vs Inpatient Chemoprophylaxis for Venous Thromboembolism in DIEP Flap Breast Reconstruction: A Systematic Review and Meta-analysis. Aesthet Surg J. 2025. PMID: 39908182. doi:10.1093/asj/sjaf024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。